小儿霍奇金淋巴瘤，2021年第3版
Pediatric Hodgkin Lymphoma, Version 3.2021.
作者信息
Flerlage Jamie E, Hiniker Susan M, Armenian Saro, Benya Ellen C, Bobbey Adam J, Chang Vivian, Cooper Stacy, Coulter Don W, Cuglievan Branko, Hoppe Bradford S, Isenalumhe Leidy, Kelly Kara, Kersun Leslie, Lamble Adam J, Larrier Nicole A, Magee Jeffrey, Oduro Kwadwo, Pacheco Martha, Price Anita P, Roberts Kenneth B, Smith Christine M, Sohani Aliyah R, Trovillion Erin M, Walling Emily, Xavier Ana C, Burns Jennifer L, Campbell Mallory
机构信息
1St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
2Stanford Cancer Institute.
出版信息
J Natl Compr Canc Netw. 2021 Jun 30;19(6):733-754. doi: 10.6004/jnccn.2021.0027.
Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.
霍奇金淋巴瘤（HL）是一种治愈率很高的癌症，目前的治疗方案侧重于提高治疗效果，同时降低治疗晚期效应的风险。美国国立综合癌症网络（NCCN）肿瘤学临床实践指南（NCCN指南）针对儿童HL提供了有关经典HL的检查、诊断评估及治疗的建议，包括病理学、影像学、分期、全身治疗及放射治疗的原则。NCCN指南的这一部分聚焦于初治及复发/难治性情况下儿童经典HL的管理。
Zotero 插件